Lazard Asset Management LLC Argenx Se Transaction History

Lazard Asset Management LLC

$63.4 Billion
Q2 2025

A detailed history of Lazard Asset Management LLC transactions in Argenx Se stock. As of the latest transaction made, Lazard Asset Management LLC holds 127,488 shares of ARGX stock, worth $102 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

127,488

Previous 70,250 81.48%

Holding current value

$102 Million

Previous $41.6 Million 69.01%

% of portfolio

0.11%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$532.27 - $656.65 $30.5 Million - $37.6 Million	57,238 Added 81.48%	127,488 $70.3 Million
Q1 2025 May 15, 2025	SELL	$571.0 - $671.75 $220,977 - $259,967	-387 Reduced 0.55%	70,250 $41.6 Million
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $33.7 Million - $41.3 Million	64,684 Added 1086.58%	70,637 $43.4 Million
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $2.41 Million - $3.07 Million	5,555 Added 1395.73%	5,953 $3.23 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $193,669 - $245,643	-544 Reduced 57.75%	398 $171,000
Q1 2024 May 14, 2024	SELL	$356.95 - $413.29 $854,538 - $989,416	-2,394 Reduced 71.76%	942 $370,000
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $391,102 - $583,935	-1,154 Reduced 25.7%	3,336 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $1.59 Million - $2.36 Million	4,310 Added 2394.44%	4,490 $2.21 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $453,215 - $547,349	-1,356 Reduced 88.28%	180 $67,000
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $460,574 - $531,096	1,342 Added 691.75%	1,536 $542,000
Q4 2021 Feb 09, 2022	SELL	$272.01 - $353.03 $50,321 - $65,310	-185 Reduced 48.81%	194 $67,000
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $1,341 - $1,901	5 Added 1.34%	379 $104,000
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $80,600 - $101,918	374 New	374 $98,000
Q4 2019 Feb 13, 2020	SELL	$106.59 - $164.21 $1.16 Million - $1.78 Million	-10,859 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $22,662 - $30,102	-200 Reduced 1.81%	10,859 $1.24 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $23,000 - $28,316	200 Added 1.84%	11,059 $1.57 Million
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $692,912 - $1.19 Million	10,859 New	10,859 $1.04 Million

Others Institutions Holding ARGX

# of Institutions

492

Shares Held

28.1M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.1B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Argenx Se Transaction History